Скачать или смотреть 2022 Diabetes Forum: Examining the Biggest Breakthroughs in Diabetes Care

TCOYD and The diaTribe Foundation’s 3rd Virtual Diabetes Forum took place July 13th, 2022, and featured an impactful and sophisticated discussion on the cutting-edge developments in diabetes from key opinion leaders. These world-renown experts shared insights on the current state of diabetes care, and discussed ground-breaking research from the 2022 ADA Scientific Sessions.

Moderators: TCOYD’s Dr. Steven Edelman & diaTribe’s Kelly Close

Panelists:
Leslie Eiland, MD (Omaha)
James Gavin, MD (Fayetteville)
Jeremy Pettus, MD (San Diego)
William Polonsky, PhD, CDCES (San Diego)
Carolyn Wysham, MD (Spokane)

Topics Included:
• What we now know about COVID-19 and diabetes
• Updates on the ADA Standards of Care
• New data on cardiovascular and renal protection outcome studies: SGLT2 inhibitors and GLP1-RAs
• The changing landscape for the treatment of obesity
• The latest in hybrid closed loop systems including Tandem CIQ, Omnipod 5, Looping, and Medtronic 780G
• CGM updates including the Eversense 180 day, Dexcom G7 and FreeStyle Libre 3
• Updates on dual- and triple- agonists in development
• Smart pens and their impact on diabetes care
• Adjunctive therapies for T1D
• Next steps on multiple cures for T1D, particularly cell-based therapy
• Telehealth and its impact
• What will truly affect social determinants of health and health equity
• “Remission” for T2D